Delivery Order SPE2DB22D1106-SPE2DB25FELZ1
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award for $16,770.31 from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,901,758 units of the drug dexmethylphenidate hydrochloride 20mg, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate...
This federal contract award is a delivery order (SPE2DB25FZ53B) issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $6,415.50 firm fixed-price contract is for the supply of 4,566,696,959 dexmethylphenidate ER 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $3,857.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,073,585 units of the drug dexmethylphenidate ER 20 mg with a completion date of April 30, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,152.26 and a completion date of June 13, 2025. The award is for the supply of 100 units of Dexmethylphenidate ER 15 mg Capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This contract is not set-aside and represents an open...
This federal contract award, valued at $3,669.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,008,730 units of the medication Dexmethylphenidate ER Capsules 25mg. This is a firm fixed-price delivery order contract with an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,195.14 firm fixed-price delivery order is for the supply of 10 mg Dexmethylphenidate tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,171.74 firm fixed price delivery order is for the supply of 4,566,281,681 units of Dexmethylphenidate ER 25 mg capsules, a treatment for ADHD. The contract has an ultimate completion date of October 31, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,551.12 firm fixed-price delivery order is for 4,566,974,492 units of Dexmethylphenidate ER 20 mg capsules, a medication used for treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,228.17, is a delivery order for the supply of 4,567,826,855 units of the drug Dexmethylphenidate ER 20 mg. The contract is a firm fixed-price arrangement with an ultimate completion date of April 8, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp...
This federal contract award, valued at $1,161.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,167,060 units of the prescription medication DEXMETHYLPHENIDATE ER 20 MG CP, with a performance period through May 7, 2025. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug...